Table 4 Significant untargeted metabolites in the cohorts (NP vs. RP).
PROLONG | DIALONG | |||||||
---|---|---|---|---|---|---|---|---|
Metabolite | ba | bb | p valuea | p valueb | ba | bb | p valuea | p valueb |
Serine1 | 0.2 | 0.1 | 0.01 | ns | 0.1 | 0.1 | ns | ns |
Phenylalanine2 | 0.3 | 0.3 | 0.01 | 0.03 | − 0.2 | − 0.1 | ns | ns |
Carnitine C42 | − 0.3 | − 0.3 | ns | ns | − 0.5 | − 0.4 | 2.4e−03 | 9.1e−03 |
Carnitine C52 | − 0.1 | − 0.1 | ns | ns | − 0.6 | − 0.6 | 6.1e−03 | 0.01 |
Erythritol1 | – | – | – | – | − 0.6 | − 0.5 | 4.3e−03 | 0.03 |
LPE C20:42 | – | – | – | – | − 0.7 | − 0.6 | 9.7e−03 | 0.03 |
Pyroglutamate1 | 0 | 0 | ns | ns | − 0.3 | − 0.3 | 0.01 | 0.03 |
Myo-inositol1 | − 0.1 | − 0.1 | ns | ns | − 0.4 | − 0.3 | 0.02 | ns |
Glutamate1 | − 0.2 | 0 | ns | ns | − 0.7 | − 0.6 | 0.02 | ns |
Hydroxyproline1 | − 0.2 | − 0.1 | ns | ns | − 0.5 | − 0.4 | 0.02 | 0.05 |
Cystine3,1 | − 0.1 | − 0.1 | ns | ns | − 0.6 | − 0.5 | 0.02 | 0.03 |
Ornithine3,1 | − 0.1 | − 0.1 | ns | ns | − 0.5 | − 0.4 | 0.02 | ns |
Hippuric acid2 | – | – | – | – | − 0.6 | − 0.5 | 0.02 | ns |
Carnitine2 | – | – | – | – | − 0.1 | − 0.1 | 0.03 | ns |
Cystine4,1 | − 0.2 | − 0.2 | ns | ns | − 0.8 | − 0.8 | 0.03 | 0.05 |
Creatinine1 | − 0.1 | − 0.1 | ns | ns | − 0.5 | − 0.4 | 0.03 | ns |